Claims

Search Type State Status Topic Model Order Counting Over

As of snapshot 27745 under ledger-default@0.3.0.

Claim	Type	Assessment	Score	Review checks	References
In this real-world case-control study, prior metformin use was not associated with a statistically distinguishable difference in SARS-CoV-2 susceptibility (aOR 0.97, 95% CI 0.81–1.16).	QUANTITATIVE	Supported	0.8581	1 of 4	100
In this real-world case-control study, prior metformin use was associated with lower odds of COVID-19 hospitalization and disease progression than use of no antidiabetic medication (hospitalization aOR 0.70, 95% CI 0.51–0.97; progression aOR 0.66, 95% CI 0.45–0.98).	QUANTITATIVE	Supported	0.8581	1 of 4	106